108 related articles for article (PubMed ID: 28944958)
1. Paclitaxel-related scleredema-like skin changes in a patient with breast cancer.
Tani N; Sugita K; Yamamoto O
Australas J Dermatol; 2018 Aug; 59(3):e215-e217. PubMed ID: 28944958
[No Abstract] [Full Text] [Related]
2. [Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma].
Eisenbeilss C; Weizel J; Wolff H
J Dtsch Dermatol Ges; 2003 Jun; 1(6):468-70. PubMed ID: 16295141
[TBL] [Abstract][Full Text] [Related]
3. [Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer].
Wu WH; Li Q; Xu BH; Zhang P; Zhao LM; Yuan P; Wang JY; Cai RG; Zhou AP
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):548-51. PubMed ID: 19062727
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.
Nowak AK; Wilcken NR; Stockler MR; Hamilton A; Ghersi D
Lancet Oncol; 2004 Jun; 5(6):372-80. PubMed ID: 15172358
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive operation for breast cancer.
Singletary SE; Dowlatshahi K; Dooley W; Hollenbeck ST; Kern K; Kuerer H; Newman LA; Simmons R; Whitworth P
Curr Probl Surg; 2004 Apr; 41(4):394-447. PubMed ID: 15114298
[No Abstract] [Full Text] [Related]
6. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced scleroderma: a pleiomorphic syndrome.
Alexandrescu DT; Bhagwati NS; Wiernik PH
Clin Exp Dermatol; 2005 Mar; 30(2):141-5. PubMed ID: 15725240
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-induced scleroderma: a case report and its role in the production of extracellular matrix.
Yang JQ; Dou TT; Chen XB; Min M; Cai SQ; Zheng M; Man XY
Int J Rheum Dis; 2017 Nov; 20(11):1835-1837. PubMed ID: 26179887
[No Abstract] [Full Text] [Related]
9. Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
O'Shaughnessy JA; Blum JL
Clin Breast Cancer; 2006 Apr; 7(1):42-50. PubMed ID: 16764743
[TBL] [Abstract][Full Text] [Related]
10. Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel).
Ghetti E; Piraccini BM; Tosti A
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):459-60. PubMed ID: 12834462
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
Spigel DR; Hainsworth JD; Burris HA; Molthrop DC; Peacock N; Kommor M; Vazquez ER; Greco FA; Yardley DA
Clin Adv Hematol Oncol; 2011 Apr; 9(4):280-6. PubMed ID: 21558987
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant clodronate in breast cancer.
Paterson AH
Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
[No Abstract] [Full Text] [Related]
13. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
Dang C; Hudis C
Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
[TBL] [Abstract][Full Text] [Related]
14. Systemic (adjuvant) treatment of primary breast cancer.
Somani N
J Assoc Physicians India; 2001 Apr; 49():451-3. PubMed ID: 11762618
[TBL] [Abstract][Full Text] [Related]
15. nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer.
Megerdichian C; Olimpiadi Y; Hurvitz SA
Cancer Treat Rev; 2014 Jun; 40(5):614-25. PubMed ID: 24560997
[TBL] [Abstract][Full Text] [Related]
16. Synchronous bilateral breast carcinoma in a patient with cowden syndrome: a case report with morphologic, immunohistochemical and genetic analysis.
Peiró G; Adrover E; Guijarro J; Ballester I; Jimenez MJ; Planelles M; Catasús L
Breast J; 2010; 16(1):77-81. PubMed ID: 19968660
[TBL] [Abstract][Full Text] [Related]
17. Pathologic findings in contralateral reduction mammaplasty specimens in patients with breast cancer.
Ramakrishnan R; Bhandare D; Fine N; Khan SA; Lal A; Nayar R
Breast J; 2005; 11(5):372-3. PubMed ID: 16174168
[No Abstract] [Full Text] [Related]
18. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Buzdar AU; Singletary SE; Valero V; Booser DJ; Ibrahim NK; Rahman Z; Theriault RL; Walters R; Rivera E; Smith TL; Holmes FA; Hoy E; Frye DK; Manuel N; Kau SW; McNeese MD; Strom E; Thomas E; Hunt K; Ames F; Berry D; Hortobagyi GN
Clin Cancer Res; 2002 May; 8(5):1073-9. PubMed ID: 12006521
[TBL] [Abstract][Full Text] [Related]
20. [Dose dense chemotherapy in the postoperative adjuvant treatment for breast cancer].
Zhou YD; Sun Q; Huan HY; Mao F; Guan JH
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):316-8. PubMed ID: 17760265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
